Connect with us

Press Releases

Prevent Blindness Names Recipient of 2016 Joanne Angle Investigator Award





Prevent Blindness Names Recipient of 2016 Joanne Angle Investigator Award
Dr. Rajeev S. Ramchandran

(Press Release)

CHICAGO – Prevent Blindness, the nation’s oldest volunteer eye health and safety organization, has announced the recipient of its 2016 Joanne Angle Investigator Award. This year’s selected recipient is Rajeev S. Ramchandran, MD, MBA, associate professor of ophthalmology, University of Rochester School of Medicine and Dentistry. Dr. Ramchandran directs the Flaum Eye Institute’s Population Vision Health Initiative at the University of Rochester Medical Center.

The Joanne Angle Investigator Award has been presented for the study, “Implementation Science Based Study of Teleophthalmology for Diabetic Retinopathy Surveillance.”

The Joanne Angle Investigator Award is a research grant presented annually to scientifically based studies that seek to end unnecessary vision loss. To date, Prevent Blindness has awarded more than $1 million to eye and vision research projects. The award was named after Joanne Angle who served with the Association for Research in Vision and Ophthalmology (ARVO) for many years as well as volunteered for Prevent Blindness as part of the National Board of Directors and various committees.
According to the Prevent Blindness study, “The Future of Vision: Forecasting the Prevalence and Costs of Vision Problem,” there are an estimated 8.1 million Americans, ages 40 and older, with diabetic retinopathy. That number is projected to increase by 35 percent to 10.9 million by 2032, and by 63 percent to 13.2 million by 2050.

Teleophthalmology for Diabetic Retinopathy Surveillance (DRS), according to Dr. Ramchandran, is the process of remotely screening diabetic patients for retinopathy. It involves placing digital non-mydriatic retinal cameras in non-ophthalmic health care settings. These cameras are linked to eye care providers via telecommunication technology, such as the internet, and their use has improved screening rates for diabetic retinopathy worldwide.


“Diabetic retinopathy is the leading cause of blindness in working age adults in the United States, resulting in significant personal, social, and economic costs and annual dilated eye exams with treatment for vision threatening retinopathy can save vision in at least 90 percent of individuals. However, the annual rate for such exams is about 50 percent for those with insurance, and even less for the underinsured,” says Dr. Ramchandran. “With support from the Joanne Angle Investigator Award from Prevent Blindness, we seek to better understand how to best deploy this new and exciting technology in the workflow of primary care clinics. This will empower primary care to join in the fight against blindness and work to increase screening for diabetic retinopathy to save the gift of sight.”

The goal and strategy of the “Implementation Science Based Study of Teleophthalmology for Diabetic Retinopathy Surveillance” project is to:
Develop an effective implementation strategy tool kit.
Refine the implementation strategy for the tool kit.
Make the tool kit available for dissemination through the Prevent Blindness network and on a publically accessible website at the University of Rochester as a standard for teleophthalmology implementation planning and program evaluation.
“The rate of diabetic eye disease continues to soar,” says Hugh R. Parry, president and CEO of Prevent Blindness. “The research from Dr. Ramchandran and his team will help us address the need for programs that can help save sight from one of the leading causes of blindness.”

For more information on the Prevent Blindness 2016 Joanne Angle Investigator Awards, or for free information on diabetic eye disease, call Prevent Blindness at (800) 331-2020 or visit



The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines





Get the most important news and business ideas for eyecare professionals every weekday from INVISION.



Most Popular